| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/07/2007 | CA2651796A1 Identification and use of novopeptides for the treatment of cancer |
| 09/07/2007 | CA2650113A1 Ankyrin-like motif-based peptides for the treatment of cancer |
| 09/07/2007 | CA2644595A1 Bispecific molecule binding tlr9 and cd32 and comprising a t cell epitope for treatment of allergies |
| 09/07/2007 | CA2644377A1 Master gene of arteriogenesis |
| 09/07/2007 | CA2644338A1 Mycobacterial disease detection, treatment, and drug discovery |
| 09/07/2007 | CA2644282A1 Virosome-like vesicles comprising gp41-derived antigens |
| 09/07/2007 | CA2643708A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/07/2007 | CA2643360A1 A novel non-selective cation channel in neuronal cells and methods for treating brain swelling |
| 09/07/2007 | CA2642994A1 Immunogenic page-4 peptides and methods of use |
| 09/07/2007 | CA2642984A1 Antibodies recognizing a highly expressed putative antigen of ca-mrsa and methods of use |
| 09/07/2007 | CA2642964A1 Plants comprising increased expression of myb-tf having increased seed yield, and a method for making same |
| 09/07/2007 | CA2642793A1 Method and apparatus for extraction of protein material from silkworm glands |
| 09/07/2007 | CA2642644A1 Antiviral agents and vaccines against influenza |
| 09/07/2007 | CA2641519A1 Compositions and methods for modulating hemostasis using variant forms of activated factor v |
| 09/07/2007 | CA2638943A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
| 09/07/2007 | CA2638832A1 Chimeric vaccine antigens against the avian influenza virus |
| 09/07/2007 | CA2638830A1 Chimeric vaccine antigens against classical swine fever virus |
| 09/07/2007 | CA2638822A1 Adir related polymorphisms and applications thereof |
| 09/07/2007 | CA2638820A1 Plants having enhanced hypersensitive response containing a nucleic acid sequence encoding nrci protein |
| 09/07/2007 | CA2638800A1 Oxyntomodulin derivatives |
| 09/07/2007 | CA2638770A1 Gene encoding trehalose-6-phosphate phosphatase and use thereof |
| 09/07/2007 | CA2638766A1 Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 09/07/2007 | CA2638764A1 Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 09/07/2007 | CA2638757A1 Chimeric adenoviral vectors |
| 09/07/2007 | CA2638734A1 Inhibitors of the unfolded protein response and methods for their use |
| 09/07/2007 | CA2638733A1 Selective vpac2 receptor peptide agonists |
| 09/07/2007 | CA2637593A1 Compounds analogous to growth hormone peptide secretagogues and preparations containing them |
| 09/07/2007 | CA2623413A1 Stem cell factor-like protein scfa1 and uses thereof |
| 09/07/2007 | CA2617600A1 Attenuated reovirus |
| 09/07/2007 | CA2604643A1 Gene encoding protein responsible for flocculation property of yeast and use thereof |
| 09/06/2007 | US20070209086 Yield-related polynucleotides and polypeptides in plants |
| 09/06/2007 | US20070209083 Cell and transgenic animal modelling human antigenic presentation and their uses |
| 09/06/2007 | US20070209082 Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| 09/06/2007 | US20070208168 Insect inhibitory Bacillus thuringiensis proteins, fusions, and methods of use therefor |
| 09/06/2007 | US20070208163 Method for treatment of protein precipitates |
| 09/06/2007 | US20070207976 Nucleic acids and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics |
| 09/06/2007 | US20070207967 Peptide Inhibitors of Matrix Metalloproteinase Activity |
| 09/06/2007 | US20070207964 Combined use of a GLP-1 compound and another drug for treating dyslipidemia |
| 09/06/2007 | US20070207961 TNF-alpha VARIANTS PROTEINS FOR THE TREATMENT OF TNF-alpha RELATED DISORDERS |
| 09/06/2007 | US20070207955 Novel polypeptide and process for producing the same, and collagenase inhibitor |
| 09/06/2007 | US20070207954 molecular weight is 15863.79 Da; has higher drug potentiation than from the mycelium of G. lucidum |
| 09/06/2007 | US20070207953 Host Defense Factor X (HDFX) |
| 09/06/2007 | US20070207952 Long Acting Biologically Active Conjugates |
| 09/06/2007 | US20070207947 Stabilized Peptides |
| 09/06/2007 | US20070207943 Interleukins-21 and 22 |
| 09/06/2007 | US20070207523 Mammalian t-type calcium channels |
| 09/06/2007 | US20070207507 Selective identification of vulnerable plaques in coronary and other arteries using non-invasive imaging methods; myeloperoxidase; acute coronary syndromes |
| 09/06/2007 | US20070207506 G-protein coupled receptor and DNA sequences thereof |
| 09/06/2007 | US20070207502 Cyclic peptides |
| 09/06/2007 | US20070207500 Affinity chromatography matrices and methods of making and using the same |
| 09/06/2007 | US20070207498 Design and construction of dimeric concanavalin a mutants |
| 09/06/2007 | US20070207464 familial juvenile gouty nephropathy (FJGN); assaying for mutations of uromodulin (UMOD) or Tamm-Horsfall glycoprotein within a test subject |
| 09/06/2007 | US20070207462 Preventive/Remedy for Respiratory Diseases |
| 09/06/2007 | US20070207166 Method of Using Adenoviral Vectors to Induce an Immune Response |
| 09/06/2007 | US20070207165 An isolated recombinant Piscirickettsia salmonis (SRS) 45 Kda (Psp45) polypeptide comprising the amino acid sequence of SEQ ID NO: 2 or NO: 4; fish diseases, particularly farmed salmon;immunogens; recombinant Yersinia ruckeri cells to be used to construct vaccines for SRS as well as other pathogens |
| 09/06/2007 | US20070207164 Methods of using flt3-ligand in the treatment of cancer |
| 09/06/2007 | US20070207163 Recombinant soluble Fc receptors |
| 09/06/2007 | US20070207160 Apoptosis inhibitors |
| 09/06/2007 | US20070207150 Annexin V is used to prevent thrombosis without increasing hemorrhage; annexin binds to phosphatidylserine on outer surface of cell membranes, thereby preventing binding of prothrombinase complex necessary for thrombus formation |
| 09/06/2007 | US20070207148 Genes associated with obesity and methods for using the same |
| 09/06/2007 | US20070207147 Nucleotide sequences coding membrane protein ; antiproliferative agents; anticancer agents; antiinflammatory agents |
| 09/06/2007 | US20070207142 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 09/06/2007 | US20070207140 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same |
| 09/06/2007 | US20070207125 Vascularized human skin equivalent |
| 09/06/2007 | US20070207111 Process For Producing Solubilized Keratin |
| 09/05/2007 | EP1830187A1 Methods of and compositions for modulating hair growth via p-cadherin modulators |
| 09/05/2007 | EP1829972A2 DNA sequences having anti-repressor activity |
| 09/05/2007 | EP1829971A1 DNA sequences having anti-repressor activity |
| 09/05/2007 | EP1829969A1 Novel polypeptide and the use thereof |
| 09/05/2007 | EP1829966A1 Peptide migrating into chromoplast in petal and method of constructing plant having yellowish petal by using the peptide |
| 09/05/2007 | EP1829963A1 Novel shuttle vector |
| 09/05/2007 | EP1829962A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 09/05/2007 | EP1829961A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited |
| 09/05/2007 | EP1829895A1 Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies |
| 09/05/2007 | EP1829893A1 Immunotherapeutic formulations with interleukin-2-neutralising capacity |
| 09/05/2007 | EP1829892A2 Staphylococcus aureus proteins and nucleic acids |
| 09/05/2007 | EP1829891A2 Immunoassays for Anti-HCV Antibodies |
| 09/05/2007 | EP1829890A1 Material for promoting the freezing of water or hydrous substance |
| 09/05/2007 | EP1829888A1 Anti-inflammatory compounds and uses thereof |
| 09/05/2007 | EP1829554A2 Site specific protein modification by mutagenesis |
| 09/05/2007 | EP1829552A2 Chlamydia PMP proteins, gene sequences and uses thereof |
| 09/05/2007 | EP1829551A1 Modified heat shock protein-antigenic peptide complex |
| 09/05/2007 | EP1829550A2 Methods for treating an ischemic disorder and improving stroke outcome |
| 09/05/2007 | EP1828403A2 Protein subcellular localization assays using split fluorescent proteins |
| 09/05/2007 | EP1828399A2 Polymer-linked pseudomonas exotoxin immunotoxin |
| 09/05/2007 | EP1828384A1 Mutant of the prob gene from coryneform bacteria |
| 09/05/2007 | EP1828378A2 Deacylation of lps in gram negative bacteria |
| 09/05/2007 | EP1828375A1 Low cell density fermentation process for the production of heterologous recombinant proteins in microorganisms |
| 09/05/2007 | EP1828372A1 New mannoprotein with full solubility in wine and its application in the stabilisation of wine |
| 09/05/2007 | EP1828246A1 Myd88 homodimerization inhibitors |
| 09/05/2007 | EP1828245A2 Igf-1 isoforms |
| 09/05/2007 | EP1828244A2 Michael-type addition reaction functionalised peg hydrogels with factor xiiia incorporated biofactors |
| 09/05/2007 | EP1828243A2 Growth hormone secretagogue receptor 1a ligands |
| 09/05/2007 | EP1828242A2 Process for preparing high levels of interferon beta |
| 09/05/2007 | EP1828241A1 G-csf polypeptides and uses thereof |
| 09/05/2007 | EP1828240A2 Novel multimeric cd40 ligands, method for preparing same and use thereof for preparing drugs |
| 09/05/2007 | EP1828239A1 Fgf18 production in prokaryotic hosts |
| 09/05/2007 | EP1828238A1 Method for isolating neural cells using tenascin-r compounds |
| 09/05/2007 | EP1828237A1 Human cancer suppressor gene, protein encoded therein, expression vector containing the same, and cell transformed by the vector |
| 09/05/2007 | EP1828236A1 Fusion proteins and methods for determining protein-protein-interactions in living cells and cell lysates, nucleic acids encoding these fusion proteins, as well as vectors and kits containing these |